Wilmington, NC – Prestige Scientific is excited to announce the successfully completed search for a Chief Medical Officer with our partner, a biopharmaceutical company leveraging its revolutionary platform to develop transformative cell therapies.
The individual hired for this role is a distinguished physician-scientist and proven leader in clinical development with deep expertise in cell and gene therapy, particularly across solid tumors and rare diseases. With a foundation in cancer biology and immunology, they have successfully led CAR-T and gene-edited therapy programs from preclinical stages through pivotal trials. Their work spans translational strategy, regulatory leadership, including multiple IND filings and FDA interactions, biomarker development, and precision medicine. Their scientific rigor, regulatory acumen, and translational insight position them at the forefront of innovation in oncology and cell therapy.
This critical hire will lead cutting-edge clinical development programs in oncology, shaping the future of innovative therapies that have the potential to transform patient outcomes. This individual will drive strategic clinical strategies, regulatory submissions, and interactions with global regulatory agencies like the FDA and EMA. They will work closely with cross-functional teams, including R&D, regulatory, and commercial, to align clinical development with broader corporate objectives.
Prestige presented 8 highly qualified individuals for this role, the hired candidate was presented 8 days from the start of the search, and the search was completed in 75 days. Congratulations to our Clinical search team for this successful partnership!
About Prestige Scientific:
Prestige Scientific is an executive search firm that advises our clients on recruiting impactful leaders. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines. We have dedicated experts in eleven practice areas that mirror a typical biopharma company, allowing us to support our client's growth from Discovery through Commercial.
